Rallybio (RLYB)
(Delayed Data from NSDQ)
$1.61 USD
+0.02 (1.26%)
Updated May 21, 2024 04:00 PM ET
After-Market: $1.61 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 35% (88 out of 248)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.40 | 1.35 | 9.99 |
Current Quarter Estimate | -0.42 | 7.43 | 57.00 |
Year Ago Quarter Estimate | -0.46 | 0.12 | 52.54 |
Next Quarter Estimate | -0.34 | 7.81 | 61.00 |
Next Year Estimate | -1.18 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 22.83 | 14.90 | 15.67 |
Next Year | 16.90 | 8.30 | 9.31 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 20.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 0.67 | 2.31 |
Price/Cash Flow (MRFY) | NA | 17.10 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -153.43% |
Return on Equity (TTM) | -66.59% | -58.74% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.